Takeshi Tada

Takeshi Tada

Auto-generated profile, based on publicly available information

Takeshi Tada

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2022 in Regenerative Therapy
Verified
Journal Article
Open access
TTTakeshi Tada
Takeshi Tada
HOHiroe Ohnishi
Hiroe Ohnishi
NYNorio Yamamoto
Norio Yamamoto
FKFumihiko Kuwata
Fumihiko Kuwata
YHYasuyuki Hayashi
Yasuyuki Hayashi
KOKoichi Omori
Koichi Omori
Early postoperative regeneration of the middle ear mucosa is essential for the prevention of postoperative refractory otitis media and recurrent cholesteatoma. As a means for intractable otitis media management, we focused on human induced pluripotent stem cell (hiPSC)-derived airway epithelial cells (AECs), which have been used in upper airway mucosal regeneration and transplantation therapy. In this study, we transplanted hiPSC-derived AECs into the middle ear of immunodeficient rats. Following the preparation of AEC sheets from hiPSCs, the bilateral middle ear mucosa of X-linked severe combined immunodeficient rats was scraped, and the AEC sheets were transplanted in the ears unilaterally. Human nuclear antigen (HNA)-positive ciliated cells were observed on the transplanted side of the middle ear cavity surface in three of six rats in the 1-week postoperative group and in three of eight rats in the 2-week postoperative group. No HNA-positive cells were found on the control side. The percentage of HNA-positive ciliated cells in the transplanted areas increased in the 2-week postoperative group compared with the 1-week group, suggesting survival of hiPSC-derived AECs. Additionally, HNA-positive ciliated cells were mainly located at sites where the original ciliated cells were localized. Immunohistochemical analysis showed that the transplanted AECs contained cytokeratin 5- and mucin 5AC-positive cells, indicating that both basal cells and goblet cells had regenerated within the middle ear cavity. The results of this study are an important first step in the establishment of a novel transplantation therapy for chronic otitis media.

3 September 2019 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
Masaomi MotegiMasaomi Motegi
Masaomi Motegi
YYYutaka Yamamoto
Yutaka Yamamoto
TTTakeshi Tada
Takeshi Tada
MTMasahiro Takahashi
Masahiro Takahashi
SSSayaka Sampei
Sayaka Sampei
HKHiromi Kojima
Hiromi Kojima
OBJECTIVES: To assess the clinical characteristics of extent patterns in pars tensa cholesteatoma. MATERIALS and METHODS: This was a retrospective chart review. Forty-four patients with pars tensa cholesteatoma who underwent primary surgery at a tertiary academic medical center were included. The main outcomes measured were sex, age, clinical background, and stage classification of pars tensa cholesteatoma (including the extent of cholesteatoma and involvement of the sinus tympani) according to two staging classifications: criteria advocated by the Japanese Otological Society (JOS) and those advocated by the European Academy of Otology and Neuro-Otology (EAONO)/JOS joint consensus statements. RESULTS: The mean patient age ± standard deviation was 38.4±19.6 years. The patients comprised 19 men and 25 women. According to the JOS classification, 18 ears (40.9%) were classified as stage I, 22 (50.0%) as stage II, and 4 (9.1%) as stage III. According to the EAONO/JOS joint consensus statements, 14 ears (31.8%) were classified as stage I, 26 (59.1%) as stage II, and 4 (9.1%) as stage III. Fourteen ears (31.8%) demonstrated involvement of the sinus tympani. Four ears (9.1%) that were originally categorized as stage I cholesteatoma by the JOS criteria showed sinus tympani invasion and were subsequently categorized as stage II according to the EAONO/JOS criteria. CONCLUSION: We determined the clinical characteristics of pars tensa cholesteatoma based on the novel and well-defined classification criteria. Further studies including long-term outcomes are necessary to demonstrate the clinical relevance of the discrepancy between the two criteria with respect to involvement of the sinus tympani. Cite this article as: Motegi M, Yamamoto Y, Tada T, Takahashi M, Sampei S, Sano H, et al. Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology & Neuro-Otology. J Int Adv Otol 2019; 15(2): 184-8.

1 January 2017 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
TTTakeshi Tada
Takeshi Tada
AHAkihiro Hitani
Akihiro Hitani
NHNatsue Hosono Honda
Natsue Hosono Honda
SHShinichi Haruna
Shinichi Haruna
TYTsuyoshi Yoshimura
Tsuyoshi Yoshimura
YTYasuhiro Tanaka
Yasuhiro Tanaka

1 July 2022 in Tissue Engineering Part A
Verified
Journal Article
Closed access
FKFumihiko Kuwata
Fumihiko Kuwata
HOHiroe Ohnishi
Hiroe Ohnishi
NYNorio Yamamoto
Norio Yamamoto
TTToshiaki Takezawa
Toshiaki Takezawa
MYMasaru Yamashita
Masaru Yamashita
KOKoichi Omori
Koichi Omori
The nasal mucosa functions as a frontline biological defense against various foreign substances and pathogens. Maintaining homeostasis of the nasal epithelium is necessary to promote good health. Nasal epithelia are constantly replaced under normal conditions. However, hereditary diseases, including primary ciliary dyskinesia and cystic fibrosis, can result in intractable dysfunction of the nasal mucosa. Since there is no treatment for this underlying condition, extrinsic manipulation is necessary to recover and maintain nasal epithelia in cases of hereditary diseases. In this study, we explored the use of airway epithelial cells (AECs), including multi-ciliated airway cells (MCACs), derived from human induced pluripotent stem cells (hiPSCs) on porcine atelocollagen vitrigel membranes, as a candidate of a therapeutic method for irreversible nasal epithelial disorders. To confirm the regenerative capacity of iPSC-derived AECs, we transplanted them into nasal cavities of nude rats. Although the transplanted cells were found within cysts isolated from the recipient nasal respiratory epithelia, they survived in some rats. Furthermore, the surviving cells were composed of multiple cell types similar to the human airway epithelia. The results could contribute to the development of novel transplantation-related technologies for the treatment of severe irreversible nasal epithelial disorders.

1 February 2024 in Tissue Engineering Part A
Verified
Journal Article
Closed access
YHYasuyuki Hayashi
Yasuyuki Hayashi
HOHiroe Ohnishi
Hiroe Ohnishi
MKMasayuki Kitano
Masayuki Kitano
YKYo Kishimoto
Yo Kishimoto
TTToshiaki Takezawa
Toshiaki Takezawa
KOKoichi Omori
Koichi Omori
The airway epithelia (AE) play a role in the clearance of foreign substances through ciliary motility and mucus secreted. We developed an artificial trachea that is made of collagen sponges and polypropylene mesh for the regeneration of the tracheal defect, and it was used for a clinical study. Then, a model in which the luminal surface of an artificial trachea covered with a human-induced pluripotent stem cell-derived AE (hiPSC-AE) was transplanted into the tracheal defect of nude rats to promote epithelialization. In the future, this model was expected to be applied to research on infectious diseases and drug discovery as a trachea-humanized rat model. However, at present, sufficient engraftment has not been achieved to evaluate functional recovery in transplanted cells. Therefore, this study focused on immunosuppression in recipient rats. Nude rats lack T-cell function and are widely used for transplantation experiments; however, more severe immunosuppressed recipients are preferred for xenotransplantation. Several strains of immunodeficient rats were created as rats that exhibit more severe immunodeficiency until now. In this study, to establish a trachea-humanized rat model in which human AE function can be analyzed to improve engraftment efficiency, engraftment efficiency in nude rats and X-linked severe combined immunodeficiency (X-SCID) rats following hiPSC-AE transplantation was compared. In the analysis of the proportion of engrafted cells in total cells at the graft site, the engraftment efficiency of epithelial cells tended to be high in X-SCID rats, although no statistical difference was found between the two groups, whereas the engraftment efficiency of mesenchymal cells was higher in X-SCID rats. Furthermore, the number of immune cells that accumulated in the grafts showed that a pan T-cell marker, i.e., CD3-positive cells, did not differ between the two strains; however, CD45-positive cells and major histocompatibility complex (MHC) class II-positive cells significantly decreased in X-SCID rats. These results indicate that X-SCID rats are more useful for the transplantation of hiPSC-AE into the tracheae to generate trachea-humanized rat models.

27 November 2022 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
Masaomi MotegiMasaomi Motegi
Masaomi Motegi
YYYutaka Yamamoto
Yutaka Yamamoto
TNTakara Nakazawa
Takara Nakazawa
TTTakeshi Tada
Takeshi Tada
MHMotoki Hirabayashi
Motoki Hirabayashi
HKHiromi Kojima
Hiromi Kojima